China
· Delayed Price · Currency is CNY China Resources Sanjiu Medical & Pharmaceutical Statistics
Total Valuation
China Resources Sanjiu Medical & Pharmaceutical has a market cap or net worth of CNY 59.59 billion. The enterprise value is 58.97 billion.
| Market Cap | 59.59B |
| Enterprise Value | 58.97B |
Important Dates
The next estimated earnings date is Monday, March 24, 2025.
| Earnings Date | Mar 24, 2025 |
| Ex-Dividend Date | Nov 29, 2024 |
Share Statistics
China Resources Sanjiu Medical & Pharmaceutical has 1.28 billion shares outstanding. The number of shares has decreased by -0.65% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.65% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 17.08% |
| Float | 473.71M |
Valuation Ratios
The trailing PE ratio is 17.38 and the forward PE ratio is 17.25. China Resources Sanjiu Medical & Pharmaceutical's PEG ratio is 1.15.
| PE Ratio | 17.38 |
| Forward PE | 17.25 |
| PS Ratio | 2.29 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 4.95 |
| P/FCF Ratio | 16.67 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.58, with an EV/FCF ratio of 16.49.
| EV / Earnings | 17.29 |
| EV / Sales | 2.28 |
| EV / EBITDA | 11.58 |
| EV / EBIT | 14.23 |
| EV / FCF | 16.49 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.88 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.53 |
| Debt / FCF | 0.75 |
| Interest Coverage | 44.10 |
Financial Efficiency
Return on equity (ROE) is 14.98% and return on invested capital (ROIC) is 9.37%.
| Return on Equity (ROE) | 14.98% |
| Return on Assets (ROA) | 6.52% |
| Return on Capital (ROIC) | 9.37% |
| Revenue Per Employee | 1.27M |
| Profits Per Employee | 167,840 |
| Employee Count | 20,318 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.43% in the last 52 weeks. The beta is 0.37, so China Resources Sanjiu Medical & Pharmaceutical's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +24.43% |
| 50-Day Moving Average | 46.41 |
| 200-Day Moving Average | 44.36 |
| Relative Strength Index (RSI) | 54.78 |
| Average Volume (20 Days) | 9,188,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, China Resources Sanjiu Medical & Pharmaceutical had revenue of CNY 25.87 billion and earned 3.41 billion in profits. Earnings per share was 2.67.
| Revenue | 25.87B |
| Gross Profit | 13.78B |
| Operating Income | 4.14B |
| Pretax Income | 4.49B |
| Net Income | 3.41B |
| EBITDA | 4.99B |
| EBIT | 4.14B |
| Earnings Per Share (EPS) | 2.67 |
Balance Sheet
The company has 8.85 billion in cash and 2.69 billion in debt, giving a net cash position of 6.16 billion or 4.79 per share.
| Cash & Cash Equivalents | 8.85B |
| Total Debt | 2.69B |
| Net Cash | 6.16B |
| Net Cash Per Share | 4.79 |
| Equity (Book Value) | 26.06B |
| Book Value Per Share | 15.99 |
| Working Capital | 10.86B |
Cash Flow
In the last 12 months, operating cash flow was 4.35 billion and capital expenditures -770.48 million, giving a free cash flow of 3.58 billion.
| Operating Cash Flow | 4.35B |
| Capital Expenditures | -770.48M |
| Free Cash Flow | 3.58B |
| FCF Per Share | 2.78 |
Margins
Gross margin is 53.24%, with operating and profit margins of 16.02% and 13.18%.
| Gross Margin | 53.24% |
| Operating Margin | 16.02% |
| Pretax Margin | 17.35% |
| Profit Margin | 13.18% |
| EBITDA Margin | 19.30% |
| EBIT Margin | 16.02% |
| FCF Margin | 13.82% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 4.31%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 4.31% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 45.00% |
| Buyback Yield | 0.65% |
| Shareholder Yield | 4.96% |
| Earnings Yield | 5.75% |
| FCF Yield | 6.00% |
Stock Splits
The last stock split was on June 14, 2024. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 14, 2024 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
China Resources Sanjiu Medical & Pharmaceutical has an Altman Z-Score of 4.06.
| Altman Z-Score | 4.06 |
| Piotroski F-Score | n/a |